Literature DB >> 2084958

Post-translational modifications of recombinant human tissue factor.

L R Paborsky1, R J Harris.   

Abstract

Recombinant human tissue factor (rTF) purified from transfected mammalian cells is a glycoprotein that contains N-linked, but not O-linked oligosaccharides. Two of the three potential N-linked sites in the extracellular portion are fully glycosylated, while one site is approximately 90% utilized. These sites have complex-type oligosaccharides attached. The potential N-linked site in the cytoplasmic domain near the C-terminus is not glycosylated. Characterization of the tryptic map of rTF confirmed most of the proposed amino acid sequence. In addition, the disulfide bonds (between Cys-49 and Cys-57 and between Cys-186 and Cys-209) were demonstrated by FAB-MS analysis of cysteine-containing fragments obtained from the tryptic map.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2084958     DOI: 10.1016/0049-3848(90)90219-3

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  15 in total

Review 1.  Tissue factor controversies.

Authors:  Kenneth G Mann; Jolanta Krudysz-Amblo; Saulius Butenas
Journal:  Thromb Res       Date:  2012-03-07       Impact factor: 3.944

2.  Low-carb tissue factor?

Authors:  J H Morrissey
Journal:  J Thromb Haemost       Date:  2011-08       Impact factor: 5.824

3.  Differences in the fractional abundances of carbohydrates of natural and recombinant human tissue factor.

Authors:  Jolanta Krudysz-Amblo; Mark E Jennings; Dwight E Matthews; Kenneth G Mann; Saulius Butenas
Journal:  Biochim Biophys Acta       Date:  2010-12-21

4.  Cystine 186-cystine 209 disulfide bond is not essential for the procoagulant activity of tissue factor or for its de-encryption.

Authors:  Hema Kothari; Ramesh C Nayak; L Vijaya Mohan Rao; Usha R Pendurthi
Journal:  Blood       Date:  2010-03-17       Impact factor: 22.113

5.  Glycosylation of tissue factor is not essential for its transport or functions.

Authors:  H Kothari; L V M Rao; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2011-08       Impact factor: 5.824

Review 6.  Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome.

Authors:  Sara C Sebag; Julie A Bastarache; Lorraine B Ware
Journal:  Curr Pharm Biotechnol       Date:  2011-09       Impact factor: 2.837

Review 7.  Tissue factor in coagulation: Which? Where? When?

Authors:  Saulius Butenas; Thomas Orfeo; Kenneth G Mann
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-10       Impact factor: 8.311

Review 8.  Posttranslational modifications and activity of natural and recombinant tissue factor.

Authors:  Saulius Butenas; Jolanta Krudysz-Amblo; Kenneth G Mann
Journal:  Thromb Res       Date:  2010-02-06       Impact factor: 3.944

9.  Carbohydrates and activity of natural and recombinant tissue factor.

Authors:  Jolanta Krudysz-Amblo; Mark E Jennings; Kenneth G Mann; Saulius Butenas
Journal:  J Biol Chem       Date:  2009-12-02       Impact factor: 5.157

Review 10.  Regulation of tissue factor coagulant activity on cell surfaces.

Authors:  L V M Rao; U R Pendurthi
Journal:  J Thromb Haemost       Date:  2012-11       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.